Clinical Trial Update: THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS [Phase 3]

View source ↗

Summary

A Phase 3 trial of the THERMOCOOL SMARTTOUCH Catheter for symptomatic paroxysmal atrial fibrillation has completed with results posted in May 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation

Drugs mentioned

• THERMOCOOL SMARTTOUCH Catheter

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2018-05-15